This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In this blog post, I’d like to go deeper into that world, and not just finding an entry-level position in a Pharma company. Let’s look at the exciting possibilities, essential skills, and valuable resources that can prepare you for success with the entry-level pharmaceutical sales. This could include therapeutic areas (e.g.,
Pharmaceuticalresearch and development: what do we get for all that money? Industry-sponsored clinical research: a broken system. Powerful medicines: the benefits, risks, and costs of prescription drugs. The post The Dark Side of the Pharmaceutical Industry: Are Treatments Being Blocked for Profit? Fugh-Berman, A.
This comes at a time when industry fart sniffing publications like Fierce Pharma report “pharma continues to shine under the pandemic spotlight. Pharma earned a solid No. Best of all are patients in the US, where prices are highest, and with chronic conditions requiring repeat prescriptions.
SUMMARY: President Biden wants to lower prescription drug costs. Even though prescription drug costs are only $.11 More new drugs are being developed by smaller biotechs who big pharma companies are acquiring as their drug candidates move through clinical trials. It is coming a lot faster now, and pharma has to be ready.
It’s a collection of measures meant to bring down prices slowly and on targeted drugs, and pharma is already complaining. Big Pharma remains the cash king. 12 of the 16 most profitable companies in Q2 were pharmaceutical firms. SUMMARY: The new, proposed, drug legislation is a first step rather than a sweeping change.
In addition to the climate provisions, however, the bill has a significant effect on prescription drug prices, and according to reports neither Manchin nor Sinema is objecting to these provisions, which are similar but not identical to the ones in the Build Back Better plan which previously passed in the House of Representatives.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content